Redox Potentials for Tetraplatin, Satraplatin, Its Derivatives, and Ascorbic Acid: A Computational Study

被引:14
作者
Sebesta, Filip [1 ]
Baxova, Katarina [1 ]
Burda, Jaroslav V. [1 ]
机构
[1] Charles Univ Prague, Fac Math & Phys, Dept Chem Phys & Opt, Ke Karlovu 3, CR-12116 Prague 2, Czech Republic
关键词
ELECTRON REDUCTION POTENTIALS; STANDARD HYDROGEN ELECTRODE; ORMAPLATIN TETRAPLATIN; SUBSTITUTION-REACTIONS; PHASE-I; MECHANISM; OXIDATION; COMPLEXES; KINETICS; ACTIVATION;
D O I
10.1021/acs.inorgchem.7b01894
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Redox potentials of the Pt(IV) complexes, such as satraplatin, tetraplatin, and several others, are determined at the density functional theory (DFT) level (with B3LYP, omega-B97XD, PBE1PBE, TPSSTPSS, M06-L, M11-L, and MN12-L functionals) and compared with post-Hartree-Fock methods MP2 and CCSD(T). Calculations are performed in water solution employing an implicit solvation model. The impact of replacement of a chloro ligand by a water molecule (hydration in the equatorial plane of the complexes) is also explored. Furthermore, an influence of solvent pH on the magnitude of the redox potentials is discussed for such hydrated complexes. The obtained results are compared with available experimental data leading to a root-mean-square deviation (RMSD) of ca. 0.23 V, using the CCSD(T)/6-31+G(d)/IEF-PCM/scaled-UAKS level. Distribution of the electron density is analyzed at the B3LYP/6-311++G(2df,2pd) level. Also, a correlation between binding energies of axial ligands and the redox potential is demonstrated. Since the Pt(IV) complexes are considered in the framework of anticancer treatment, possible reducing agents in bioenvironment are searched. From this reason, the reduction potential of different protonation states of ascorbic acid is also presented.
引用
收藏
页码:951 / 962
页数:12
相关论文
共 63 条
  • [1] Toward reliable density functional methods without adjustable parameters: The PBE0 model
    Adamo, C
    Barone, V
    [J]. JOURNAL OF CHEMICAL PHYSICS, 1999, 110 (13) : 6158 - 6170
  • [2] Phase 1 Trial and Pharmacokinetic Study of the Oral Platinum Analog Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors
    Akshintala, Srivandana
    Marcus, Leigh
    Warren, Katherine E.
    Murphy, Robert F.
    Sissung, Tristan M.
    Srivastava, Anjali
    Goodspeed, Wendy J.
    Goodwin, Anne
    Brewer, Carmen C.
    Zalewski, Christopher
    King, Kelly A.
    Kim, AeRang
    Figg, William D.
    Widemann, Brigitte C.
    [J]. PEDIATRIC BLOOD & CANCER, 2015, 62 (04) : 603 - 610
  • [3] Theoretical Investigation into the Mechanism of 3′-dGMP Oxidation by [PtIVCl4(dach)]
    Ariafard, Alireza
    Ghohe, Narges Mandizadeh
    Abbasi, Kiana Khadem
    Canty, Allan J.
    Yates, Brian F.
    [J]. INORGANIC CHEMISTRY, 2013, 52 (02) : 707 - 717
  • [4] KINETICS AND MECHANISM OF THE COMPLEXATION OF CIS-DIAMMINEDICHLOROPLATINUM(II) WITH THE PURINE NUCLEOSIDE INOSINE IN AQUEOUS-SOLUTION
    ARPALAHTI, J
    MIKOLA, M
    MAURISTO, S
    [J]. INORGANIC CHEMISTRY, 1993, 32 (15) : 3327 - 3332
  • [5] Ball EG, 1937, J BIOL CHEM, V118, P219
  • [6] A new definition of cavities for the computation of solvation free energies by the polarizable continuum model
    Barone, V
    Cossi, M
    Tomasi, J
    [J]. JOURNAL OF CHEMICAL PHYSICS, 1997, 107 (08) : 3210 - 3221
  • [7] MECHANISMS OF EXCHANGE AND SUBSTITUTION REACTIONS IN PLATINUM(IV) COMPLEXES
    BASOLO, F
    MESSING, AF
    WILKS, PH
    WILKINS, RG
    PEARSON, RG
    [J]. JOURNAL OF INORGANIC & NUCLEAR CHEMISTRY, 1958, 8 : 203 - 208
  • [8] BASOLO F, 1961, ADV INORG CHEM, V3, P1
  • [9] DENSITY-FUNCTIONAL THERMOCHEMISTRY .3. THE ROLE OF EXACT EXCHANGE
    BECKE, AD
    [J]. JOURNAL OF CHEMICAL PHYSICS, 1993, 98 (07) : 5648 - 5652
  • [10] Satraplatin: leading the new generation of oral platinum agents
    Bhargava, Ashish
    Vaishampayan, Ulka N.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (11) : 1787 - 1797